US2008145454A1PendingUtilityA1
Compositions to alleviate herpes virus symptoms
Est. expiryDec 15, 2026(~0.4 yrs left)· nominal 20-yr term from priority
Inventors:Jeffrey Wycoff
A61P 43/00A61K 36/22A61P 31/12A61K 36/71A61K 45/06A61K 36/185
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions and methods of preparing and using such compositions to treat the symptoms of herpes virus.
Claims
exact text as granted — not AI-modified1 . A dosage form of a homeopathic composition, comprising:
a) an amount of Rhus toxicondendron; b) an amount of Ranunculus bulbosus; c) an amount of Phytolacca decandra ; and d) an amount of Malus pumila.
2 . The dosage form of a homeopathic composition as described in claim 1 , further comprising at least one component selected from the group consisting of: an amount of Natrum mauriacticum and an amount of Borax.
3 . The dosage form of a homeopathic composition as described in claim 2 , wherein said amount of Rhus toxicondendron comprises an amount of Rhus toxicondendron of between about 6× HPUS and about 200c HPUS, and wherein said amount of Ranunculus bulbosus comprises an amount of Ranunculus bulbosus of between about 3× HPUS and about 200c HPUS, and wherein said amount of Phytolacca decandra comprises an amount of Phytolacca decandra of between about 3× HPUS and about 200c HPUS, and wherein said amount of Malus pumila comprises an amount of Malus pumila of between 3× and about 200c.
4 . The dosage form of a homeopathic composition as described in claim 3 , wherein said amount of Natrum mauriacticum comprises and amount of Natrum mauriacticum of between about 3× HPUS and about 200c HPUS.
5 . The dosage form of a homeopathic composition as described in claim 3 , wherein said amount of Borax comprises an amount of Borax of between about 6× HPUS and about 200c HPUS.
6 . The dosage form of a homeopathic composition as described in claim 3 , wherein said amount of Rhus toxicondendron of between about 6× HPUS to about 200c HPUS comprises and amount of Rhus toxicondendron of about 30× HPUS, and wherein amount of Ranunculus bulbosus of between about 3× HPUS to about 200c HPUS comprises an amount of Ranunculus bulbosus of about 12× HPUS, and wherein said amount of Phytolacca decandra of between about 3× HPUS to about 200c HPUS comprises an amount of Phytolacca decandra of about 3× HPUS, and wherein said amount of Malus pumila comprises an amount of Malus pumila of about 5×.
7 . The dosage form of a homeopathic composition as described in claim 6 , wherein said amount of Natrum mauriacticum comprises an amount of Natrum mauriacticum of about 30× HPUS.
8 . The dosage form of a homeopathic composition as described in claim 6 , wherein said amount of Borax comprises an amount of Borax of about 1× HPUS.
9 . The dosage form of a homeopathic composition as described in claim 8 , wherein said amount of Natrum mauriacticum comprises and amount of Natrum mauriacticum of about 30× HPUS.
10 . The dosage form of a homeopathic composition as described in claim 9 , wherein said dosage form comprises a liquid dosage form.
11 . The dosage form of a homeopathic composition as described in claim 10 , wherein said liquid dosage form provides a liquid spray.
12 . The dosage form of a homeopathic composition as described in claim 9 , where said dosage form comprises an oral solid dosage form.
13 . The dosage form of a homeopathic composition as described in claim 12 , wherein said oral solid dosage form comprises a tablet dosage form.
14 . The dosage form of a homeopathic composition as described in claim 9 , wherein said dosage form comprises a topical cream.
15 - 28 . (canceled)Join the waitlist — get patent alerts
Track US2008145454A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.